Timothy T. Richards net worth and biography

Timothy Richards Biography and Net Worth

Director of ClearPoint Neuro

Timothy T. Richards joined our Board in March 2014. Mr. Richards serves as the Chief Business Officer at Jana Care, a venture capital funded company focused on chronic kidney and heart disease testing and monitoring, a position he has held since December 2021. Prior to joining Jana Care, Mr. Richards was Chief Commercial Officer for YourBio Health (formerly Seventh Sense BioSystems, Inc.), and former President of Facet Technologies, LLC, a privately held supplier to major diagnostic companies. Additionally, Mr. Richards held executive-level positions within the Covidien organization, first as U.S. President of the Patient Care & Safety Products business unit and subsequently as President of VNUS Medical Technologies following its acquisition by Covidien in 2009. From October 2003 through October 2008, Mr. Richards served as Senior Vice President, Chief Marketing Officer and a member of the Executive Board of B. Braun Medical, Inc. Before joining B. Braun Medical, he held a number of progressive leadership positions throughout the U.S. and in Asia with Becton Dickinson and Company. We believe Mr. Richards brings to our Board extensive leadership experience and expertise in general management, manufacturing and R&D operations, commercial management and strategy in relevant markets and technologies.

What is Timothy T. Richards' net worth?: The estimated net worth of Timothy T. Richards is at least $1.09 million as of June 10th, 2025. Richards owns 77,381 shares of ClearPoint Neuro stock worth more than $1,087,977 as of December 5th. This net worth evaluation does not reflect any other assets that Richards may own. Learn More about Timothy T. Richards' net worth.
How do I contact Timothy T. Richards?: The corporate mailing address for Richards and other ClearPoint Neuro executives is 5 MUSICK, IRVINE CA, 92618. ClearPoint Neuro can also be reached via phone at (949) 900-6833 and via email at [email protected]. Learn More on Timothy T. Richards' contact information.
Has Timothy T. Richards been buying or selling shares of ClearPoint Neuro?: Timothy T. Richards has not been actively trading shares of ClearPoint Neuro within the last three months. Most recently, Timothy T. Richards sold 10,000 shares of the business's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $13.28, for a transaction totalling $132,800.00. Following the completion of the sale, the director now directly owns 77,381 shares of the company's stock, valued at $1,027,619.68. Learn More on Timothy T. Richards' trading history.
Who are ClearPoint Neuro's active insiders?: ClearPoint Neuro's insider roster includes Joseph Burnett (CEO), Joseph Burnett (President & CEO), and Timothy Richards (Director). Learn More on ClearPoint Neuro's active insiders.
Are insiders buying or selling shares of ClearPoint Neuro?: During the last year, insiders at the sold shares 3 times. They sold a total of 57,710 shares worth more than $1,129,144.37. The most recent insider tranaction occured on October, 10th when CEO Joseph Burnett sold 26,463 shares worth more than $713,971.74. Insiders at ClearPoint Neuro own 7.0% of the company. Learn More about insider trades at ClearPoint Neuro.
Information on this page was last updated on 10/10/2025.

Timothy T. Richards Insider Trading History at ClearPoint Neuro

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/10/2025	Sell	10,000	$13.28	$132,800.00	77,381

Timothy T. Richards Buying and Selling Activity at ClearPoint Neuro

ClearPoint Neuro Company Overview

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Today's Range

Now: $14.06

$13.60

$14.19

50 Day Range

MA: $20.41

$13.34

$29.60

2 Week Range

Now: $14.06

$9.76

$30.10

Volume

479,612 shs

Average Volume

717,307 shs

Market Capitalization

$399.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01